UPDATE 1-AerCap confirms plane-leasing company talks with Standard Electric powered
TipRanksBillionaire David Tepper Bets Huge on These 2 “Strong Buy” Dividend SharesAnybody striving to hold keep track of of where...
Update
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results
PCDH19 related epilepsy (PCDH19-RE) Phase 2 Violet Study Proof-of-Concept Trial (n=21) shows a median 61.5% reduction in seizure frequency for...
Titan Medical Issues Corporate Update
Large market opportunity, strong corporate foundation, innovative robotic-assisted technologyClinical studies expected to commence in 2022Titan Medical Inc. ("Titan" or the...
UPDATE 1-Hole weighing sale of China business enterprise- Bloomberg Information
TipRanksAI Is In this article 3 ‘Strong Buy’ Shares That Stand to AdvantageHi tech is the interesting child of expense...
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020Conference call and webcast on Tuesday, March 9,...
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Sale of Manufacturing Operations to Catalent with net proceeds of ~$74 millionAnnual operating expenses cut by ~$40 million via sale,...
UPDATE 1-Dassault to unveil enterprise jet, sees decrease deliveries
TipRanksThe Bottom Is in for These 3 Shares? Analysts Say ‘Buy’Hardly ever say that one human being tends to make...
ObsEva Announces Year End 2020 Financial Results and Business Update
-Yselty® for uterine fibroids: US New Drug Application filing planned in Q2:21; European marketing approval anticipated in Q4:21--Yselty® for endometriosis:...
Eloxx Prescription drugs to Report Fourth Quarter and Total Year 2020 Money Final results and Offer Enterprise Update on March 11, 2021
Organization administration to host a webcast and conference phone to present a small business update and overview financial success at...
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results
Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and...
Ascendis Pharma A/S Announces Full 12 months 2020 Economical Outcomes and Enterprise Update Convention Call on March 10
COPENHAGEN, Denmark, March 04, 2021 (World NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical business that makes use of...
Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today provided a business update and...
VYNE Therapeutics Reports Year-End 2020 Financial Results and Provides Business Update
Conference call and live webcast to discuss financial results and new FMX114 program in atopic dermatitis today, Thursday, March 4,...
argenx Reports Full Year 2020 Financial Results and Provides Fourth Quarter Business Update
- Biologics License Application (BLA) for IV efgartigimod accepted for review by U.S. Food and Drug Administration (FDA) for generalized...
Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update
FDA recommends we conduct a randomized, double-blinded, placebo-controlled Phase II for Intravenous (IV) and Inhaled Ampion to allow consideration of...
Globalstar Announces 2020 Financial Results and Business Update
Globalstar, Inc. (NYSE American: GSAT) today announced financial and operating results for the fourth quarter and year ended December 31,...
Spero Therapeutics to Present Company Update and Report Fourth Quarter and Full-Year 2020 Monetary Success on Thursday, March 11, 2021
CAMBRIDGE, Mass., March 03, 2021 (World NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical corporation centered on...
